Dr. James D. Bergin, M.D.
Heart Failure & Transplant Cardiology (Advanced Heart Failure and Transplant Cardiology Physician)
- Medicare participating
At a glance
- Medical school
- Tufts University School of Medicine (1984)
- Years since graduation
- 42
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 901
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1984Medical school: Tufts University School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Advanced Heart Failure and Transplant Cardiology Physician primary
VA license 0101045352
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Map: Heart Failure & Transplant Cardiology per capita by county →
Where they work
Hospitals
- University of Virginia Medical Center Charlottesville, VA
- Carilion Medical Center Roanoke, VA
- Centra Health - Lynchburg Gen Hospital Lynchburg, VA
- Augusta Health Fishersville, VA
- Uva Health Culpeper Medical Center Culpeper, VA
Medical groups
- University of Virginia Physicians Group (1,717 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 901
- Services billed
- 2,349
- Patients’ average age
- 74
| Service | Times | Patients |
|---|---|---|
| Established patient office or other outpatient visit, 30-39 minutes | 747 | 490 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 332 | 85 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 240 | 214 |
| Established patient office or other outpatient visit, 20-29 minutes | 208 | 180 |
| Evaluation of lower heart chamber assist device | 172 | 24 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 80 | 30 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 60 | 54 |
| Hospital discharge day management, 30 minutes or less | 48 | 43 |
| New patient office or other outpatient visit, 45-59 minutes | 33 | 33 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 28 | 27 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Metoprolol Succinate Other prescribers in Charlottesville, VA | 573 |
| Furosemide Other prescribers in Charlottesville, VA | 429 |
| Eliquis (apixaban) Other prescribers in Charlottesville, VA | 415 |
| Carvedilol Other prescribers in Charlottesville, VA | 409 |
| Spironolactone Other prescribers in Charlottesville, VA | 372 |
| Entresto (sacubitril/valsartan) Other prescribers in Charlottesville, VA | 336 |
| Atorvastatin Calcium Other prescribers in Charlottesville, VA | 327 |
| Losartan Potassium Other prescribers in Charlottesville, VA | 268 |
| Lisinopril Other prescribers in Charlottesville, VA | 260 |
| Farxiga (dapagliflozin propanediol) Other prescribers in Charlottesville, VA | 187 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $22,000 in research payments for these studies, mostly to the institutions running them.
- Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
Procyrion, Inc. · Recruiting · NCT05677100
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.